MedPath

Comparison of the Effects of Calcium, Vitamin D, and Calcium plus Vitamin D On Anthropometric Indices, Body Composition, Lipid Profile, Blood Pressure, and Blood Glucose in Overweight or Obese Premenopausal women.

Not Applicable
Conditions
overweight and obesity.
Obesity due to excess calories
Registration Number
IRCT2014021116555N1
Lead Sponsor
Shiraz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
100
Inclusion Criteria

inclusion criteria: premenopausal women; age between 20-50 years; BMI between 25-40 kg/m2; not having any cancer or severe endocrine, mental, hepatic, renal, gastrointestinal, cardiovascular, neurologic, rheumatologic, hematologic, skeletal, and eating disorders; not taking any medication, nutritional supplements, or herbal preparations that could affect calcium and vitamin D status, anthropometric indices, body composition, lipid profile, blood pressure, and blood glucose during the last 12 weeks; not having any history of drug intolerance or adverse reaction to the study supplements; Dairy product consumption of =3 serving /d; consumption of =5 cups of coffee/d; not being pregnant or lactating; not being a smoker or taking alcohol; not being a participant in other trials over the last 6 months; Stable body weight (body weight change?3 kg for 3mo before intervention); providing written informed consent.
exclusion criteria: development of serious adverse events during the study period and lack of adherence to the study protocol.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Waist circumference. Timepoint: At the beginning and at the end of the intervention. Method of measurement: Tape measure.;Body mass index. Timepoint: At the beginning and at the end of the study. Method of measurement: BMI will be calculated as weight (kg)/ height (m)2.;Body fat mass. Timepoint: At the beginning and at the end of the intervention. Method of measurement: Bioelectric impedance analyzer.;Lipid profile. Timepoint: At the beginning and at the end of the intervention. Method of measurement: By use of bt 1500 set and pars test kit.;Blood pressure. Timepoint: At the beginnig and at the end f the intervention. Method of measurement: mmHg-piezometer.;Blood glucose. Timepoint: At the beginnig and at the end f the study. Method of measurement: by Autoanalyzer method using Pars test kit.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath